Skip to main content
Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.45
-1.70 (-7.67%)
At close: Mar 9, 2026

Daiken Biomedical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022
Period Ending
 Mar '26 Dec '24 Dec '23 Dec '22
Market Capitalization
16,56510,860--
Enterprise Value
11,5219,874--
Last Close Price
20.4517.34--
PE Ratio
46.81101.90--
PS Ratio
9.297.97--
PB Ratio
3.108.31--
P/TBV Ratio
3.108.33--
P/FCF Ratio
56.12215.06--
P/OCF Ratio
56.01209.86--
EV/Sales Ratio
6.467.25--
EV/EBITDA Ratio
41.2564.48--
EV/EBIT Ratio
42.2266.31--
EV/FCF Ratio
39.04195.53--
Debt / Equity Ratio
0.000.001.120.60
Debt / EBITDA Ratio
0.070.011.351.21
Debt / FCF Ratio
0.070.052.633.27
Net Debt / Equity Ratio
-0.94-0.87-0.04-0.47
Net Debt / EBITDA Ratio
-18.06-7.43-0.05-0.96
Net Debt / FCF Ratio
-17.09-22.52-0.10-2.59
Asset Turnover
0.481.191.87-
Inventory Turnover
1.781.991.71-
Quick Ratio
17.915.360.801.23
Current Ratio
19.436.561.642.17
Return on Equity (ROE)
8.09%13.71%67.55%-
Return on Assets (ROA)
4.63%8.15%20.01%-
Return on Invested Capital (ROIC)
195.95%55.95%94.00%77.31%
Return on Capital Employed (ROCE)
5.10%11.40%68.80%38.90%
Earnings Yield
1.62%0.98%--
FCF Yield
1.78%0.46%--
Dividend Yield
1.82%2.33%--
Payout Ratio
193.78%2.89%87.59%-
Buyback Yield / Dilution
-77.82%-95.20%-44.34%-
Total Shareholder Return
-76.00%-92.87%-44.34%-
Source: S&P Capital IQ. Standard template. Financial Sources.